Oscar Health, Inc. (NYSE:OSCR) Shares Purchased by Amalgamated Bank

Amalgamated Bank increased its stake in Oscar Health, Inc. (NYSE:OSCR) by 27.7% during the second quarter, HoldingsChannel.com reports. The fund owned 6,727 shares of the company’s stock after buying an additional 1,458 shares during the period. Amalgamated Bank’s holdings in Oscar Health were worth $106,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Price T Rowe Associates Inc. MD increased its stake in Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after purchasing an additional 2,409,160 shares in the last quarter. Iron Triangle Partners LP bought a new position in Oscar Health during the fourth quarter valued at about $18,781,000. First Light Asset Management LLC lifted its position in shares of Oscar Health by 117.3% in the first quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after buying an additional 1,134,919 shares during the last quarter. Renaissance Technologies LLC boosted its stake in shares of Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after acquiring an additional 934,600 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its holdings in shares of Oscar Health by 161.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock valued at $22,038,000 after acquiring an additional 860,226 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Oscar Health

In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $286,488.58. Following the transaction, the executive vice president now owns 392,607 shares of the company’s stock, valued at $6,697,875.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now directly owns 76,982 shares of the company’s stock, valued at approximately $1,384,906.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $17.06, for a total transaction of $286,488.58. Following the transaction, the executive vice president now owns 392,607 shares of the company’s stock, valued at $6,697,875.42. The disclosure for this sale can be found here. Insiders have sold 169,569 shares of company stock worth $3,007,069 in the last three months. Insiders own 25.11% of the company’s stock.

Oscar Health Stock Down 2.7 %

Shares of OSCR opened at $20.63 on Wednesday. The company has a market capitalization of $4.89 billion, a P/E ratio of -51.58, a PEG ratio of 43.01 and a beta of 1.61. Oscar Health, Inc. has a one year low of $4.72 and a one year high of $23.79. The business’s 50 day simple moving average is $18.70 and its 200-day simple moving average is $17.93. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same quarter in the prior year, the business earned ($0.07) earnings per share. The business’s revenue for the quarter was up 44.6% on a year-over-year basis. As a group, sell-side analysts predict that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on OSCR. Wells Fargo & Company boosted their target price on Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a report on Wednesday, June 12th. Piper Sandler restated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $24.17.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.